| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |